The National Institutes of Health (NIH) is offering a funding opportunity titled "Blueprint MedTech Translator (UG3/UH3 - Clinical Trial Optional)" aimed at advancing the development of therapeutic and diagnostic devices for neurological and neuromuscular disorders. This initiative encourages investigators to engage in translational activities and clinical feasibility studies, focusing on device implementation, non-clinical safety testing, regulatory approvals, and subsequent clinical studies. The program operates under a milestone-driven cooperative agreement framework, emphasizing collaboration with NIH staff throughout the project lifecycle, and is open to a diverse range of applicants, including underrepresented groups and various institutions. Interested parties must submit their applications by September 27, 2024, and can find additional information and application details at the NIH grants website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.